Video
Factors in Selecting Therapy at First Relapse in Multiple Myeloma
Shared insight from experts in multiple myeloma on patient and disease characteristics that inform selection of best therapy at first relapse.
EP: 1.What is the Role of Transplant in Newly Diagnosed Multiple Myeloma?
EP: 2.NDMM: Identifying Patient and Disease Factors to Select Appropriate Therapy
EP: 3.Induction Therapy Regimens for Transplant-Eligible NDMM
EP: 4.Impact of Risk Status on Treatment Pathways in Newly Diagnosed Multiple Myeloma
EP: 5.Treatment Options for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
EP: 6.Determining Frailty in Patients With Newly Diagnosed Multiple Myeloma
EP: 7.Treatment Duration in Patients With Newly Diagnosed Multiple Myeloma
EP: 8.Patient Scenario: Treatment Options in MM at First Relapse
Now Viewing
EP: 9.Factors in Selecting Therapy at First Relapse in Multiple Myeloma
EP: 10.Patient Scenario: Bispecifics in MM After Multiple Prior Lines of Therapy
EP: 11.Multiple Myeloma: Sequencing Novel Therapies in Later Lines of Treatment
EP: 12.Bispecifics in Multiple Myeloma: Dosing and Transition of Care
EP: 13.Combination Strategies With Bispecifics in Multiple Myeloma
EP: 14.Bispecifics in Multiple Myeloma: Adverse Event Management
EP: 15.CAR T-Cell Therapy in Multiple Myeloma: Updates from ASCO 2023 and Beyond
EP: 16.Multiple Myeloma: Unmet Needs and Future Directions in Care
Related Videos
Related Content
